Patents by Inventor Anadruzela S. Vallari

Anadruzela S. Vallari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human immunodeficiency virus and uses thereof
    Patent number: 9150834
    Abstract: The present invention relates to Human Immunodeficiency Virus-1 (HIV-1) Group P of the strain designated 06CMU14788 and fragments thereof, primers which are derived from HIV-1 Group P, immunogenic regions thereof, immunoassays and nucleic acid based assays for the detection of Human Immunodeficiency Virus (HIV) that employ said HIV-1 Group P or fragments thereof and therapeutic compositions containing said HIV-1 Group P or fragments thereof.
    Type: Grant
    Filed: February 16, 2011
    Date of Patent: October 6, 2015
    Assignee: ABBOTT LABORATORIES
    Inventors: Catherine A. Brennan, Vera Holzmayer, Anadruzela S. Vallari, Julie Yamaguchi
  • Human Immunodeficiency Virus And Uses Thereof
    Publication number: 20110281258
    Abstract: The present invention relates to Human Immunodeficiency Virus-1 (HIV-1) Group P of the strain designated 06CMU14788 and fragments thereof, primers which are derived from HIV-1 Group P, immunogenic regions thereof, immunoassays and nucleic acid based assays for the detection of Human Immunodeficiency Virus (HIV) that employ said HIV-1 Group P or fragments thereof and therapeutic compositions containing said HIV-1 Group P or fragments thereof.
    Type: Application
    Filed: February 16, 2011
    Publication date: November 17, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Catherine A. Brennan, Vera Holzmayer, Anadruzela S. Vallari, Julie Yamaguchi
  • Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups
    Patent number: 5922533
    Abstract: A method of performing a rapid assay for the simultaneous detection and differentiation of the analytes HIV-1 group M. HIV-1 group O and HIV-2 utilizing a sequence specific polypeptide of each analyte as capture reagents. An analytical. device also is provided for performing the method which includes these capture reagents. Also provided is a test kit which includes the analytical device which further can include a positive and negative control.
    Type: Grant
    Filed: August 15, 1997
    Date of Patent: July 13, 1999
    Assignee: Abbott Laboratories
    Inventors: Anadruzela S. Vallari, John R. Hackett, Jr., Robert K. Hickman, Vincent A. Varitek, Jr., Elizabeth C. Necklaws, Alan M. Golden, Catherine A. Brennan, Sushil G. Devare